Table 1.
Demographic and clinical participant characteristics
| Group |
Sex
(f./m.) |
Age
(years) |
ERQ
Reappraisal (pts.) |
ERQ
Suppression (pts.) |
MADRS
(pts.) |
SDMT
(#corr. trials) |
STAI-State
(pts.) |
STAI-
Trait (pts.) |
EDSS
(pts.) |
Disease duration
(years) |
|---|---|---|---|---|---|---|---|---|---|---|
| # | MN | MN | MN | MN | MN | MN | MN | MD | MN | |
| SD | SD | SD | SD | SD | SD | SD | RG | SD | ||
|
Pw
MSD |
14 | 47.9 | 28.7 | 14.9 | 17.6 | 54.1 | 46.2 | 48.6 | 2.5 | 15.2 |
| 2 | 11.8 | 4.74 | 3.46 | 6.46 | 8.26 | 9.14 | 8.16 | 1.0-6.0 | 10.3 | |
| PwMS | 14 | 47.3 | 27.7 | 13.4 | 1.31 | 53.4 | 31.5 | 32.5 | 2.5 | 12.8 |
| 12 | 11.7 | 5.95 | 5.57 | 1.19 | 10.5 | 6.28 | 5.56 | 0.0 –6.0 | 7.8 | |
| χ2 | t | t | t | t § | t | t | t | T | t | |
| P | P | P | P | P | P | P | P | P | P | |
| 4.73 | 0.15 | 0.54 | 0.96 | 12.6 | 0.23 | 6.19 | 7.64 | 1.32 | 0.84 | |
| 0.03 | 0.88 | 0.59 | 0.34 | 8·10−16 | 0.59 | 10−7 | 10−9 | 0.10 | 0.20 |
Undirected tests were conducted for sex, age, and both ERQ measures (i.e. P-values corresponded to two-sided tests), directed tests for all other measures (i.e. P-values correspond to one-sided tests). ERQ – Reappraisal, habitual application of the emotion regulation strategy ‘reappraisal’. ERQ – Suppression, habitual application of the emotion regulation strategy ‘suppression’; MADRS, Montgomery-Asberg Depression Rating Scale; SDMT, Symbol Digit Modalities Test. STAI, State – State anxiety. STAI – Trait – Trait anxiety; corr, correct; f./m., female/male; pts., points. §Please note that we report measures of inferential statistics for MADRS group differences only for the sake of completeness. From a statistical viewpoint, the parameters reported are meaningless as the group assignment was performed based on MADRS.